May 15, 2018 / 4:57 PM / 2 months ago

BRIEF-FDA Approves Expanded Indication For Truvada

May 15 (Reuters) - Gilead Sciences Inc:

* U.S. FOOD AND DRUG ADMINISTRATION APPROVES EXPANDED INDICATION FOR TRUVADA® (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE) FOR REDUCING THE RISK OF ACQUIRING HIV-1 IN ADOLESCENTS

* GILEAD SCIENCES - U.S. FDA HAS APPROVED ONCE-DAILY ORAL TRUVADA TO REDUCE RISK OF SEXUALLY ACQUIRED HIV-1 IN AT-RISK ADOLESCENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below